Masimo SedLine® Brain Function Monitoring Reduces Use of Powerful Drugs During Heart Surgery
Researchers found that using Masimo's SedLine brain-function monitoring during cardiac surgery reduced the use of anesthetic agents and opioids.
In a retrospective study published in the Journal of Cardiothoracic and Vascular Anesthesia, researchers at the Montreal Heart Institute found that processed electroencephalography (pEEG)-guided anesthesia was associated with reduced use of vasoactive and inotropic drugs, as well as lesser use of anesthetic agents and opioids in the OR, lower central venous pressure (CVP), lesser fluid administration, lesser intraoperative bleeding, and shorter duration on mechanical ventilation.
High postoperative doses of vasoactive and inotropic drugs have been associated with mortality and renal dysfunction, the researchers noted. They sought to determine whether use of pEEG-guided anesthesia, which may improve hemodynamic stability, might improve out
comes by reducing the use of these agents during cardiac surgery and afterward in the ICU.
The primary goal of the study was to determine whether pEEG-guided anesthesia would be associated with reduced hemodynamic instability during cardiopulmonary bypass (CPB) separation. This was measured by stratifying the operation into three categories: “easy,” meaning use of only one vasoactive or one inotropic agent; “difficult,” meaning use of at least two different classes of agents; or “complex,” meaning requiring a return to CPB or use of mechanical circulatory support.
Determining if pEEG-guided anesthesia would lead to the hypothesized reduction in vasoactive and inotropic drug administration in the ICU was the secondary goal of the study. This was measured b
y vasoactive and inotropic score (VIS).
The study looked at a retrospective cohort of 300 adult patients who underwent cardiac surgery using CPB between 2013 and 2020, at the Montreal Heart Institute. The patients were divided into two groups, depending on whether anesthesia was guided by pEEG, which became a standard of care in 2017. The patients in the pEEG group had their brain function monitored from the moment they entered the OR to when they arrived in the ICU, using Masimo’s SedLine.
The pEEG group of patients received fewer vasoactive and inotropic drugs in the first hour after ICU admission, resulting in lower VIS scores. Additionally, being in the pEEG group reduced the odds of being in a higher VIS category by 57%. Other outcomes were also lower with this group, includ
ing duration of mechanical ventilation, intraoperative fluid balance, and the amount of bleeding.
A lower proportion of this group experienced unsuccessful CPB separation than the control group. However, after adjusting for other parameters using multiple logistic regression, use of pEEG-guided anesthesia was not independently associated with successful CPB separation; instead, the re
searchers note, unsuccessful separation was associated with several independent known predictors of hemodynamic complications.
Full Details on the Study can be read here
Norso Medical Ltd. is the sole exclusive sales/service agent for:
Mindray Patient Monitors, Ultrasound, and Integration & Connectivity
Masimo Co Oximetry including SpHb, Sedline 4Ch EEG, O3 cerebral monitoring and other connected devices.
Masimo ISirona – Hospital automation platform for EMR Integration
LIDCO hemodynamic monitoring
Monivent® Neo 100 & Monivent® Neo Training
Lifecast Body Simulation (NI Only)
Clear Diamond Screen protection
ADC Range of Primary care devices